The CEO/CFO sales are small relative to market cap and likely reflect routine portfolio diversification rather than a bearish signal. The CBO's subsequent small buy is not enough to offset the sales. Monitor for any upcoming clinical data readouts or financing events that could explain the timing.
Price Chart
Executive Summary
A mixed insider cluster at Corbus Pharmaceuticals shows the CEO and CFO selling a combined $292K in open-market sales on August 7, while the Chief Business Officer made a small $25K open-market purchase four days later. The sales are modest relative to the $184M market cap (~0.16%), and the buy is trivial (~0.01%), making this cluster unlikely to signal a material change in the company's outlook.
Key Financial Metrics
Key Facts
- CEO Yuval Cohen sold 17,000 shares for $171,396 on August 7, 2026.
- CFO Sean Moran sold 12,000 shares for $120,971 on August 7, 2026.
- CBO Nishant Saxena purchased 2,600 shares for $25,036 on August 11, 2026.
- Total insider sales of $292K represent ~0.16% of CRBP's $184M market cap.
- The cluster is mixed — two senior executives sold while one executive bought a small amount.
Financial Impact
Total insider sales of $292K are modest at ~0.16% of market cap; the $25K purchase is negligible at ~0.01%.
Risk Factors
- CEO and CFO selling on the same day could indicate coordinated insider sentiment ahead of a catalyst.
- The CBO's buy is too small to be a strong conviction signal.
- No material corporate events (earnings, data readouts) are referenced in the cluster window.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-CRBP-1786611892720 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | 8-K | $4.33 | awaiting T+60 | — | $4.15 (−4.16%) |
Sep 30, 2026 27d ago | SC 13G | $6.34 | awaiting T+60 | — | $4.15 (−34.54%) |
Sep 22, 2026 5w ago | Institutional Cluster | $7.88 | awaiting T+60 | — | $4.15 (−47.30%) |
Sep 14, 2026 6w ago | 8-K | $8.08 | awaiting T+60 | — | $4.15 (−48.64%) |
Sep 11, 2026 6w ago | Press Release | $8.08 | awaiting T+60 | — | $4.15 (−48.64%) |
Aug 12, 2026 10w ago | Insider Cluster | $10.08 | awaiting T+60 | — | $4.15 (−58.83%) |
Aug 10, 2026 11w ago | Insider Cluster | $9.51 | awaiting T+60 | — | $4.15 (−56.36%) |
May 26, 2026 22w ago | 8-K | $7.91 $9.99 | ▲ +26.30% | ▲ +23.57% | $4.15 (−47.53%) |
May 21, 2026 22w ago | 8-K | $11.51 $10.49 | ▼ −8.86% | ▼ −13.16% | $4.15 (−63.94%) |
May 14, 2026 23w ago | 8-K | $11.98 $9.46 | ▼ −21.04% | ▼ −24.62% | $4.15 (−65.36%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers